Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. Velu
A Double-Blind Study to Determine the Maximum Tolerated Dose of Ethionamide, When Administered Twice-Weekly to Patients With Pulmonary Tuberculosis
Tubercle
Related publications
Study of Twice-Weekly Injections of Teriparatide by Comparing Efficacy With Once-Weekly Injections in Osteoporosis Patients: The TWICE Study
Osteoporosis International
Medicine
Endocrinology
Metabolism
Diabetes
An Application of Reinforced Urn Processes to Determining Maximum Tolerated Dose
Statistics and Probability Letters
Uncertainty
Statistics
Probability
Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic Cancer
Clinical Cancer Research
Cancer Research
Oncology
High-Dose Vitamin D3 During Intensive-Phase Antimicrobial Treatment of Pulmonary Tuberculosis: A Double-Blind Randomised Controlled Trial
The Lancet
Medicine
Potentially Serious Side Effects of High-Dose Twice-Weekly Rifampicin
BMJ
A Double Blind Comparative Study on a Nonsteroidal Anti-Inflammatory Drug, TA-60, in Pain After Dental Extraction. In Order to Determine Optimal Dose.
Japanese Journal of Oral & Maxillofacial Surgery
Dose Titration Algorithm Tuning (DTAT) Should Supersede ‘The’ Maximum Tolerated Dose (MTD) in Oncology Dose-Finding Trials
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
“Maximum Tolerated Dose” Versus “Fixed Low-Dose” Hydroxyurea for Treatment of Adults With Sickle Cell Anemia
American Journal of Hematology
Hematology
Maximum Tolerated Dose Evaluation of the AMPA Modulator Org 26576 in Healthy Volunteers and Depressed Patients
Drugs in R and D
Pharmacology
